UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Journal of allergy and clinical immunology, 2012-07, Vol.130 (1), p.145-154.e9

2012

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

The Lancet (British edition), 2009-02, Vol.373 (9664), p.633-640

2009

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis

The Journal of dermatological treatment, 2017-07, Vol.28 (5), p.384-389

2017

Link zum Volltext

Verfügbarkeit prüfen

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

The New England journal of medicine, 2017-03, Vol.376 (9), p.826-835

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

The New England journal of medicine, 2016-07, Vol.375 (4), p.345-356

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

The Lancet (British edition), 2018-06, Vol.391 (10136), p.2213-2224

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Link zum Volltext

Verfügbarkeit prüfen

43799 Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB42-AB42

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

The New England journal of medicine, 2021-02, Vol.384 (6), p.512-520

2021

Link zum Volltext

Verfügbarkeit prüfen

26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB96-AB96

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica

The New England journal of medicine, 2023-02, Vol.388 (6), p.511-517

2023

Link zum Volltext

Verfügbarkeit prüfen

Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study

Journal of cutaneous medicine and surgery, 2022-07, Vol.26 (4), p.377-385

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics

Skin (Milwood, N.Y.), 2019-11, Vol.3, p.S22

2019

Link zum Volltext

Verfügbarkeit prüfen

Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study

Dermatology and therapy, 2017-12, Vol.7 (4), p.447-461

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

International journal of dermatology, 2006-05, Vol.45 (5), p.605-614

2006

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of hand and foot psoriasis with efalizumab therapy

Journal of drugs in dermatology, 2006-10, Vol.5 (9), p.838

2006

Link zum Volltext

Verfügbarkeit prüfen

IL-17A is Essential for Cell Activation and Inflammatory Gene Circuits in Psoriasis

Journal of allergy and clinical immunology, 2012-06, Vol.130 (1), p.145-54.e9

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and therapeutics: Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

International journal of dermatology, 2006-05, Vol.45 (5), p.605-614

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis : A phase illb, randomized, controlled trial

International journal of dermatology, 2006, Vol.45 (5), p.605-614

2006

Link zum Volltext

Verfügbarkeit prüfen

Eccrine syringofibroadenoma : a clear-cell variant

The American journal of dermatopathology, 1995-12, Vol.17 (6), p.591-593

1995

Link zum Volltext

Verfügbarkeit prüfen

Ignition potential of the 585-nm pulsed-dye laser : Review of the literature and safety recommendations

Dermatologic surgery, 1996-08, Vol.22 (8), p.699-702

1996

Link zum Volltext

Verfügbarkeit prüfen

Ignition Potential of the 585‐nm Pulsed‐Dye Laser

Dermatologic surgery, 1996-08, Vol.22 (8), p.699-702

1996

Link zum Volltext

Verfügbarkeit prüfen

A Drosophila melanogaster H3.3 cDNA encodes a histone variant identical with the vertebrate H3.3

Gene, 1991-11, Vol.107 (2), p.341-342

1991

Link zum Volltext

Verfügbarkeit prüfen

Penile erythematous eruption in a man with diabetes

Archives of dermatology (1960), 1999-07, Vol.135 (7), p.845, 848

1999

Link zum Volltext

Verfügbarkeit prüfen

Epidermolysis bullosa acquisita and inflammatory bowel disease

JAMA : the journal of the American Medical Association, 1983-10, Vol.250 (13), p.1746

1983

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Dermatology
(13)
Male
(12)
Female
(11)
Adult
(10)
Biological And Medical Sciences
(9)
Middle Aged
(9)
Medical Sciences
(8)
Double-Blind Method
(7)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Patients
(7)
Psoriasis
(7)
Treatment Outcome
(7)
Aged
(6)
Antibodies, Monoclonal - Therapeutic Use
(6)
Clinical Trials
(6)
Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

43799 Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica

Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics

Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

Successful treatment of hand and foot psoriasis with efalizumab therapy

IL-17A is Essential for Cell Activation and Inflammatory Gene Circuits in Psoriasis

Pharmacology and therapeutics: Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis : A phase illb, randomized, controlled trial

Eccrine syringofibroadenoma : a clear-cell variant

Ignition potential of the 585-nm pulsed-dye laser : Review of the literature and safety recommendations

Ignition Potential of the 585‐nm Pulsed‐Dye Laser

A Drosophila melanogaster H3.3 cDNA encodes a histone variant identical with the vertebrate H3.3

Penile erythematous eruption in a man with diabetes

Epidermolysis bullosa acquisita and inflammatory bowel disease

Suchergebnisse filtern